{
    "eid": "2-s2.0-85149508076",
    "title": "Human Rabies Vaccines",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology and Microbiology (all)",
            "@code": "2400",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "CCV",
        "Exposure",
        "PEP",
        "Potency",
        "Rabies",
        "Vaccines"
    ],
    "authors": [
        "Deborah J. Briggs",
        "Thiravat Hemachudha"
    ],
    "citedby-count": 1,
    "ref-count": 79,
    "ref-list": [
        "Rabies: Changing prophylaxis and new insights in pathophysiology",
        "A large-scale, rapid public health response to rabies in an organ recipient and the previously undiagnosed organ donor",
        "Estimating the global burden of endemic canine rabies",
        "Human rabies: A disease of complex neuropathogenetic mechanisms and diagnostic challenges",
        "Human rabies: Neuropathogenesis, diagnosis, and management",
        "Rabies",
        "Rabies virus infection: An update",
        "Current status and development of vaccines and other biologics for human rabies prevention",
        "The global availability of rabies immune globulin and rabies vaccine in clinics providing indirect care to travelers",
        "Rabies vaccines: From the past to the 21st century",
        "Louis Pasteur (1822-95)",
        "Rabies vaccines",
        "Epidemiology of animal bites and other potential rabies exposures and antirabies vaccine utilization in a rural area in Southern Ethiopia",
        "Human pre-exposure rabies immunization with suckling mouse brain vaccine",
        "Laboratory techniques in rabies: Suckling mouse brain vaccine",
        "Adverse reactions associated with a Fuenzalida-Palacios rabies vaccine: A quasi-experimental study",
        "The Middle East and Eastern Europe rabies Expert Bureau (MEEREB) third meeting: Lyon-France (7-8 April, 2015)",
        "Progress towards eliminating canine rabies: Policies and perspectives from Latin America and the Caribbean",
        "Novel vaccines to human rabies",
        "A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine",
        "Immunogenicity of purified duck embryo rabies vaccine (Lyssavac-N) with use of the WHO-approved intradermal postexposure regimen",
        "Matrix and backstage: Cellular substrates for viral vaccines",
        "Vero cell platform in vaccine production: Moving towards cell culture-based viral vaccines",
        "Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): An immunogenic, cost-effective and practical regimen",
        "Comparison of safety and immunogenicity of PVRV and PCECV immunized in patients with WHO category II animal exposure: A study based on different age groups",
        "Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine",
        "Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post-exposure prophylaxis of rabies",
        "Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine",
        "Evaluation of a human diploid cell strain rabies vaccine: Final report of a three year study of pre-exposure immunization",
        "Immunization with a human diploid cell strain of rabies virus vaccine: Two-year results",
        "Rabies vaccines",
        "Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally. (Results of a prospective randomized trial)",
        "Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy",
        "Post exposure rabies prophylaxis with purified verocell rabies vaccine: A study of immunoresponse in pregnant women and their matched controls",
        "Rabies vaccines",
        "Rabies vaccines: WHO position paper-recommendations",
        "Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: Investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine",
        "Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines when administered by intradermal route: Results of a metaanalysis",
        "Laboratory techniques in rabies. Potency-test requirements of the United States National Institutes of Health (NIH)",
        "Laboratory techniques in rabies: The NIH test for potency",
        "Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines",
        "Replacing the NIH test for rabies vaccine potency testing: A synopsis of drivers and barriers",
        "Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use",
        "A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use",
        "Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA-results of an international collaborative study",
        "Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals",
        "Reduction of animal suffering in rabies vaccine potency testing by introduction of humane endpoints",
        "Concepts in the pathogenesis of rabies",
        "Characterization of the equilibrium between the native and fusion-inactive conformation of rabies virus glycoprotein indicates that the fusion complex is made of several trimers",
        "Differential stability and fusion activity of Lyssavirus glycoprotein trimers",
        "Additional reports of failure to respond to treatment after rabies exposure in Thailand",
        "Failures of post-exposure rabies prophylaxis",
        "Failure of postexposure treatment of rabies in children",
        "Postexposure prophylaxis for rabies with antiserum and intradermal vaccination",
        "Reducing the cost of post-exposure rabies prophylaxis: Efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals",
        "Elimination of human rabies in a canine endemic province in Thailand:Five-year programme",
        "Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals",
        "30 Years of rabies vaccination with Rabipur: A summary of clinical data and global experience",
        "Rabies post-exposure prophylaxis in malnourished children exposed to suspect rabid animals",
        "Immune response to rabies vaccination in pediatric transplant patients",
        "Restoration of the antibody response upon rabies vaccination in HIV-infected patients treated with HAART",
        "Survival of neutralizing antibody in previously rabies vaccinated subjects:A prospective study showing long lasting immunity",
        "Rabies vaccine response measurement is assay dependent",
        "The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays",
        "Human rabies prevention-United States, 2008: Recommendations of the Advisory Committee on Immunization Practices",
        "The burden of rabies in Tanzania and its impact on local communities",
        "A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen",
        "Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment",
        "Enhancement of immunogenicity and efficacy of a plasmid DNA rabies vaccine by nanoformulation with a fourth-generation amine-terminated poly(ether imine) dendrimer",
        "Green synthesis and evaluation of silver nanoparticles as adjuvant in rabies veterinary vaccine",
        "Future prospects for the development of cost-effective adenovirus vaccines"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Manhattan",
            "@id": "60000689",
            "affilname": "Kansas State University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000689",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}